Global Tuberculosis Diagnostic Market

Posted by kalpesh rajput on April 20th, 2021

Global Tuberculosis Diagnostic Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 5.2% during the forecast period. Global Tuberculosis Diagnostic Market Overview: Tuberculosis or TB is an infectious disease caused by Mycobacterium tuberculosis bacteria. Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms and this is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. Global Tuberculosis Diagnostic Market Dynamics: Rising Burden of Tuberculosis and Multi-drug Resistant Tuberculosis (MDR TB) are the primary factors driving the market growth. According to the World Health Organization (WHO), about 10 million people are affected by tuberculosis, each year. Further, tuberculosis is the leading cause of death from a single infectious agent, ranking above HIV/AIDS. The rise in initiatives by governments and independent organizations to control the spread of tuberculosis is also contributing to the growth of the global tuberculosis diagnostics market. An increase in expenditure on R&D activities for the development of novel tuberculosis diagnostic procedures will be a major factor for the growth of the tuberculosis diagnostics market growth in the forecast period. However, the high cost associated with the Tuberculosis testing procedure may hamper the market growth. The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region. Global Tuberculosis Diagnostic Market Segment Analysis: The Global Tuberculosis Diagnostic Market is segmented on the basis of Test Type and End-users. Based on Test Type, the Nucleic Acid Testing segment is projected to hold a significant market share. Nucleic acid testing of tuberculosis provides a higher level of accuracy and higher speed than culture-based tests, which is a factor driving the growth of the nucleic acid testing segment. The segment is expected to witness a CAGR of 5.4% over the forecast years. Global Tuberculosis Diagnostic Market1 To Know About The Research Methodology :- Request Free Sample Report Global Tuberculosis Diagnostic Market Regional Insights: Global Tuberculosis Diagnostic Market2 Asia Pacific is expected to witness lucrative market growth during forecast period. Due to the high burden of tuberculosis as well as the rapid proliferation of this disease the region is expected to dominate the market. Countries, such as India, China, Indonesia, and Afghanistan are among the top-priority countries for the control of communicable diseases, according to the WHO. China and India registered the highest number of new cases of tuberculosis annually, followed by African and Latin American countries. The report also helps in understanding Global Tuberculosis Diagnostic Market dynamics, structure by analyzing the market segments and project the Global Tuberculosis Diagnostic Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Tuberculosis Diagnostic Market make the report investor’s guide. Key Developments: In June 2018, Qiagen set up new guidelines from the American Academy of Pediatrics (AAP) for screening children as young as two years old, for latent tuberculosis infection. Global Tuberculosis Diagnostic Market Scope: Inquire before buying Global Tuberculosis Diagnostic Market3 Global Tuberculosis Diagnostic Market, By Region: • North America • Europe • South America • MEA • APAC Global Tuberculosis Diagnostic Market, key players: • Thermo Fisher Scientific, Inc. • Alere, Inc. • Becton • Dickinson and Company • F. Hoffmann-La Roche AG • LIONEX Diagnostics & Therapeutics GmbH • Danaher Corporation • Creative Diagnostics • QIAGEN • Oxford Immunotec Ltd. • Hologic, Inc. • Cepheid • Akonni Biosystems, Inc. • bioMerieux SA • Epistem Ltd. This report submitted by Maximize market Research Company Customization of the report: Maximize MarketResearch provides free personalized of reports as per your demand.This reportcan be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities. About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors. Contact info: Name: Lumawant Godage Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD. Email: sales@maximizemarketresearch.com Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India. Contact: +919607195908